Información:
Error:
ID
28337
Descripción
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Visit: All Visits Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Palabras clave
Versiones (5)
- 30/11/17 30/11/17 -
- 30/11/17 30/11/17 -
- 7/12/17 7/12/17 -
- 10/12/17 10/12/17 -
- 4/1/18 4/1/18 -
Titular de derechos de autor
Prof. Dr. med. Georg Heß
Subido en
4 de enero de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Signature GOAL Trial B-cell Lymphoma NCT02499003
Signature GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Signature GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
confirmation patient information
Item
I have reviewed this eCRF and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient. All entries were made either by me or by a person under my supervision who has signed the Delegation and Signature Log
boolean
C0521091 (UMLS CUI [1,1])
C1955348 (UMLS CUI [1,2])
C1955348 (UMLS CUI [1,2])
Date of signature
Item
Date of signature
date
C0807937 (UMLS CUI [1])
Name of investigator
Item
Name of investigator
text
C2826892 (UMLS CUI [1])
Sin comentarios